Tender Details

Country: USA
Summary: Production of Biologically Derived Small Molecule Regulatory Starting Materials And/Or Active Pharmaceutical Ingredients at Commercial Scale
UST Ref No: 95360312
Deadline: 01 Feb 2024
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.:
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Description
ASPR IBMSC through the BARDA PCI BioMaP-Consortium is seeking to develop a biological design-build-test cycle at population scale, beginning with an analytical/paper demonstration of production of small molecule drug substances at commercial scale. This objective will support ASPR IBMSC-s broader long-term goal of developing and commercializing infrastructure that will be accessible to a broad community of users for the purpose of three biologically derived small molecule drug substances, creating a new manufacturing paradigm that can be competitive in the global market and to onshore drug production. The objective of this project is to demonstrate the ability to produce three (3) biologically derived small molecule drug substances at population scale.
You can find the solicitation on the BioMaP-Consortium website here: https://www.biomap-consortium.org/24-01-smallmol/.
Submissions must be made through the BioMaP-Consortium website ONLY.
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Production of Biologically Derived Small Molecule Regulatory Starting Materials And/Or Active Pharmaceutical Ingredients at Commercial Scale - USA Tender

The HEALTH AND HUMAN SERVICES, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for Production of Biologically Derived Small Molecule Regulatory Starting Materials And/Or Active Pharmaceutical Ingredients at Commercial Scale. This tender is published on USARFP under UST Ref No: 95360312 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-02-01.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.